A trial of clenbuterol in bronchial asthma.
Clenbuterol is a beta 2-sympathomimetic bronchodilator. In a double-blind cross-over trial in 19 asthmatic patients with reversible airways obstruction, oral administration of both clenbuterol (40 microgram) and salbutamol (4 mg) caused significantly greater increased in peak expiratory flow rate (P...
Guardat en:
| Publicat a: | Thorax |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1977
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC470819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/341407/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.32.6.717 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|